#173 Hypercoagulability Workup: 5 Pearls Segment

#173 Hypercoagulability Workup: 5 Pearls Segment

A new way to think of clots beyond provoked vs. unprovoked: Learn all about how important it is to think about reversibility! What patient states affect the inherited thrombophilia testing? Learn the nuances and practical approaches!

🔹 Sponsor: Freed is an AI scribe that listens and writes your note in < 30 seconds. Freed learns your style over time and is HIPAA compliant!

Use the code CORE50 to get 50% off your first month with Freed

🔹 This episode is also sponsored by Factor! Get fresh, ready-made meals delivered to your door. Use the code factorpodcast for a special discount at factor75.com.

Transcript and Show Notes

Timestamps:

(02:07) | Pearl 1: Reframing Provoked vs. Unprovoked to Reversibility

(09:12) | Pearl 2: How can Virchow's Triad help us categorize the etiology of a clot?

(17:01) | Pearl 3: What factors affect anti-thrombin III, Protein C and Protein S deficiency

(28:50) | Pearl 4: Is the Factor V Leiden or Prothrombin Gene Mutation as important as the family history?

(38:41) | Pearl 5: Spaced Repetition of Learning Points

Tags: CoreIM, Internal Medicine, ClinicalPearls, Medical Education, IMCore, hospitalist, physician assistant, nurse practitioner, medical student, internal medicine, hematology



Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840

Our Sponsors:
* Check out Quince: https://quince.com/coreim
* Use code FIGSRX for a great deal: https://wearfigs.com


Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Avsnitt(213)

#181 July Stories 3.0

#181 July Stories 3.0

Listen for some good laughs and relatable stories!In this episode, we share raw and real stories from July — from rapid responses to unexpected kindness — and reflect on the emotional weight of starti...

2 Juli 202515min

#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group

#180 Beta-Blockers & REDUCE-AMI Trial: Beyond Journal Club Segment with NEJM Group

How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and exp...

25 Juni 202526min

#179 Invasive Fungal Disease: 5 Pearls Segment

#179 Invasive Fungal Disease: 5 Pearls Segment

🔹 What is invasive fungal disease, and who is most at risk for developing invasive fungal disease? (~ 02:46)🔹 What are the main classes of fungi? (~11:35)🔹 What are the pros and cons of B-D Glucan ...

11 Juni 202545min

#178 Continuous Glucose Monitor (CGM): 5 Pearls Segment

#178 Continuous Glucose Monitor (CGM): 5 Pearls Segment

🔹What are clinically relevant limitations of an A1c vs. a CGM (1:40)🔹What do the different parts of the ambulatory glucose profile tell you? (09:59)🔹What are common pitfalls, medications, lifestyle...

2 Juni 202533min

#177 Interventional Radiology (IR) 101: 5 Pearls Segment

#177 Interventional Radiology (IR) 101: 5 Pearls Segment

🔹When is an U/S vs. CT vs. MRI helpful before consulting Interventional Radiology?🔹What factors go into an IR pre-op evaluation?🔹 When do drains go in, and when do they come out?🔹 When a patient h...

14 Maj 202543min

#176 Constipation Medications: 5 Pearls Segment

#176 Constipation Medications: 5 Pearls Segment

🔹 High-yield reversible causes of constipation? (02:26)🔹 Which type of fiber is more helpful? And is more hydration really better? And bulk-forming laxatives (9:03)🔹 Osmotic vs Stimulant Laxatives ...

30 Apr 202539min

#175 A Revolution in HIV Prevention & The PURPOSE Trials: Beyond Journal Club Segment with NEJM Group

#175 A Revolution in HIV Prevention & The PURPOSE Trials: Beyond Journal Club Segment with NEJM Group

How good are we at preventing HIV? How do efficacy and effectiveness differ? We journey from oral pre-exposure prophylaxis (PrEP) to long-acting injectables, and then to the PURPOSE trials, which look...

16 Apr 202527min

#174 Lp(a) and ASCVD Risk: 5 Pearls Segment

#174 Lp(a) and ASCVD Risk: 5 Pearls Segment

What does Lipoprotein(a) tell us that a standard lipid panel doesn’t? Should we be testing everyone for it? Dive into the genetics, clinical implications, and evolving management strategies for Lp(a)....

2 Apr 202543min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
nu-blir-det-historia
harrisons-dramatiska-historia
johannes-hansen-podcast
allt-du-velat-veta
not-fanny-anymore
rss-viktmedicinpodden
rss-foraldramotet-bring-lagercrantz
roda-vita-rosen
sektledare
i-vantan-pa-katastrofen
sa-in-i-sjalen
rss-max-tant-med-max-villman
alska-oss
rss-sjalsligt-avkladd
rss-om-vi-ska-vara-arliga
rss-basta-livet
sex-pa-riktigt-med-marika-smith